Login to Your Account

Gottlieb vows action on drug cost issue in budget hearing

By Mark McCarty
Regulatory Editor

Thursday, May 25, 2017

The latest FDA commissioner may be in an uncomfortable place where the Trump administration's budget proposal is concerned, but Scott Gottlieb told a congressional committee that the agency will undertake several actions to bolster competition in the drug marketplace.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription